References
- Bolis G, Bonazzi C, Landoni F, et al (1998). EMA/CO regimen in high-risk gestational trophoblastic tumor (GTT). Gynecol Oncol, 31, 439-44. https://doi.org/10.1016/S0090-8258(88)80029-5
- Bower M, Newlands ES, Holden L, et al (1997). EMA/CO for high-risk gestational trophoblastic tumors: results from a cohort of 272 patients. J Clin Oncol, 15, 2636-43. https://doi.org/10.1200/JCO.1997.15.7.2636
- Miller AV, Hoogstralen B, Staquet M, et al (1981). Reporting results of cancer treatment. Cancer, 47, 297-14.
- Matsui H, Suzuka K, Iitsuka Y, et al (2002). Salvage combination chemotherapy with 5-fluorouracil and actinomycin D for patients with refractory, high-risk gestational trophoblastic tumors. Cancer, 95, 1051-4. https://doi.org/10.1002/cncr.10790
- Lurain JR, Singh DK, Schink JC (2006). Primary treatment of metastatic high-risk gestational trophoblastic neoplasia with EMA-CO chemotherapy. J Reprod Med, 51, 767-72.
- Wang S, An R, Han X, Zhu K, Xue Y (2006). Combination chemotherapy with 5-fluorouracil, methotrexate and etoposide for patients with high-risk gestational trophoblastic tumors: a report based on our 11-year clinical experiences. Gynecol Oncol, 103, 1105-8. https://doi.org/10.1016/j.ygyno.2006.06.031
- Zhao Y, Zhang W, Duan W (2009). Management of gestational trophoblastic neoplasia with 5-fluorouracil and actinomycin D in northern China. J Reprod Med, 54, 88-94.
Cited by
- Predictive Role of the Neutrophil Lymphocyte Ratio for Invasion with Gestational Trophoblastic Disease vol.15, pp.10, 2014, https://doi.org/10.7314/APJCP.2014.15.10.4203
- Multicenter Analysis of Gestational Trophoblastic Neoplasia in Turkey vol.15, pp.8, 2014, https://doi.org/10.7314/APJCP.2014.15.8.3625
- Management of Chemoresistant and Quiescent Gestational Trophoblastic Disease vol.3, pp.1, 2014, https://doi.org/10.1007/s13669-013-0071-6
- Tegafur Substitution for 5-Fu in Combination with Actinomycin D to Treat Gestational Trophoblastic Neoplasm vol.10, pp.11, 2015, https://doi.org/10.1371/journal.pone.0143531
- Quality of Life in Gestational Trophoblastic Neoplasia Patients after Treatment in Thailand vol.15, pp.24, 2015, https://doi.org/10.7314/APJCP.2014.15.24.10871
- Human Chorionic Gonadotropin (hCG) Regression Curve for Predicting Response to EMA/CO (Etoposide, Methotrexate, Actinomycin D, Cyclophosphamide and Vincristine) Regimen in Gestational Trophoblastic Neoplasia vol.16, pp.12, 2015, https://doi.org/10.7314/APJCP.2015.16.12.5037
- Outcomes of Non-Metastatic Gestational Trophoblastic Neoplasia: Twelve Year Experience from a Northern Thailand Tertiary Care Center vol.16, pp.14, 2015, https://doi.org/10.7314/APJCP.2015.16.14.5913
- FIGO stage IV gestational choriocarcinoma misdiagnosed as pulmonary tuberculosis: A�case report pp.1792-1082, 2015, https://doi.org/10.3892/ol.2015.3443
- Outcomes of Metastatic Gestational Trophoblastic Neoplasia: Fourteen Year Experience from a Northern Thailand Tertiary Care Center vol.17, pp.3, 2016, https://doi.org/10.7314/APJCP.2016.17.3.1357
- Uterine artery embolization combined with local infusion of methotrexate and 5- fluorouracil in treating ectopic pregnancy vol.97, pp.5, 2018, https://doi.org/10.1097/MD.0000000000009722